OrthoPediatrics (NASDAQ:KIDS) Major Shareholder Sells $525,375.00 in Stock

Posted by George Bondi on Sep 4th, 2026

OrthoPediatrics Corp. (NASDAQ:KIDS – Get Free Report) major shareholder Squadron Capital Llc sold 22,500 shares of the firm’s stock in a transaction dated Wednesday, September 2nd. The stock was sold at an average price of $23.35, for a total value of $525,375.00. Following the completion of the sale, the insider directly owned 6,504,133 shares in the company, valued at approximately $151,871,505.55. The trade was a 0.34% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Major shareholders that own more than 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

Squadron Capital Llc also recently made the following trade(s):

On Friday, August 28th, Squadron Capital Llc sold 326,700 shares of OrthoPediatrics stock. The shares were sold at an average price of $23.04, for a total value of $7,527,168.00.
On Tuesday, September 1st, Squadron Capital Llc sold 10,131 shares of OrthoPediatrics stock. The shares were sold at an average price of $23.10, for a total transaction of $234,026.10.
On Wednesday, August 26th, Squadron Capital Llc sold 18,000 shares of OrthoPediatrics stock. The stock was sold at an average price of $24.28, for a total transaction of $437,040.00.
On Tuesday, August 25th, Squadron Capital Llc sold 16,300 shares of OrthoPediatrics stock. The shares were sold at an average price of $24.74, for a total transaction of $403,262.00.
On Monday, August 24th, Squadron Capital Llc sold 4,000 shares of OrthoPediatrics stock. The stock was sold at an average price of $25.75, for a total transaction of $103,000.00.

OrthoPediatrics Trading Down 0.8%

Shares of KIDS traded down $0.18 during mid-day trading on Friday, reaching $22.41. The company had a trading volume of 129,506 shares, compared to its average volume of 173,525. OrthoPediatrics Corp. has a fifty-two week low of $14.42 and a fifty-two week high of $26.74. The firm has a fifty day simple moving average of $21.74 and a 200-day simple moving average of $18.84. The stock has a market cap of $585.13 million, a price-to-earnings ratio of -13.34 and a beta of 0.99. The company has a current ratio of 4.78, a quick ratio of 2.17 and a debt-to-equity ratio of 0.28.

OrthoPediatrics (NASDAQ:KIDS – Get Free Report) last issued its earnings results on Tuesday, August 4th. The company reported ($0.26) earnings per share for the quarter, topping the consensus estimate of ($0.30) by $0.04. OrthoPediatrics had a negative return on equity of 8.10% and a negative net margin of 15.72%.The business had revenue of $70.51 million for the quarter, compared to analyst estimates of $68.21 million. On average, sell-side analysts anticipate that OrthoPediatrics Corp. will post -1.14 EPS for the current fiscal year.

Institutional Investors Weigh In On OrthoPediatrics

Several large investors have recently modified their holdings of KIDS. Millennium Management LLC lifted its stake in OrthoPediatrics by 48.0% during the fourth quarter. Millennium Management LLC now owns 1,396,495 shares of the company’s stock valued at $24,802,000 after buying an additional 452,840 shares in the last quarter. BlackRock Inc. acquired a new stake in shares of OrthoPediatrics during the second quarter worth approximately $24,347,000. Vanguard Group Inc. grew its position in OrthoPediatrics by 1.1% during the third quarter. Vanguard Group Inc. now owns 961,330 shares of the company’s stock valued at $17,813,000 after purchasing an additional 10,927 shares in the last quarter. Granahan Investment Management LLC increased its stake in OrthoPediatrics by 35.1% in the 1st quarter. Granahan Investment Management LLC now owns 896,741 shares of the company’s stock valued at $14,231,000 after buying an additional 232,760 shares during the period. Finally, Wasatch Advisors LP lifted its position in OrthoPediatrics by 56.6% in the 2nd quarter. Wasatch Advisors LP now owns 515,677 shares of the company’s stock worth $9,865,000 after buying an additional 186,357 shares in the last quarter. 69.05% of the stock is owned by institutional investors.

Analyst Ratings Changes

KIDS has been the topic of a number of recent research reports. Needham & Company LLC lifted their price target on shares of OrthoPediatrics from $30.00 to $35.00 and gave the company a “buy” rating in a research report on Wednesday, August 5th. Truist Financial set a $22.00 price target on shares of OrthoPediatrics in a report on Wednesday, August 5th. Weiss Ratings raised OrthoPediatrics from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Wednesday, August 5th. TD Cowen reiterated a “buy” rating on shares of OrthoPediatrics in a research note on Monday, June 15th. Finally, Piper Sandler reaffirmed an “overweight” rating and set a $25.00 target price (up from $22.00) on shares of OrthoPediatrics in a report on Wednesday, August 5th. Nine analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $26.44.

Read Our Latest Report on OrthoPediatrics

OrthoPediatrics Company Profile

(Get Free Report)

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.